Table of Contents Europe Tissue Engineered Skin Substitutes Market Report 2012-2023 1 Tissue Engineered Skin Substitutes Overview 1.1 Product Overview and Scope of Tissue Engineered Skin Substitutes 1.2 Classification of Tissue Engineered Skin Substitutes by Product Category 1.2.1 Europe Tissue Engineered Skin Substitutes Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Europe Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Types in 2017 1.2.3 Acellular 1.2.4 Cellular Allogeneic 1.2.5 Cellular Autologous 1.2.6 Others 1.3 Europe Tissue Engineered Skin Substitutes Market by Application/End Users 1.3.1 Europe Tissue Engineered Skin Substitutes (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Burn Injury 1.3.3 Diabetic 1.3.4 Vascular Ulcer 1.3.5 Others 1.4 Europe Tissue Engineered Skin Substitutes Market by Region 1.4.1 Europe Tissue Engineered Skin Substitutes Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Germany Status and Prospect (2012-2023) 1.4.3 UK Status and Prospect (2012-2023) 1.4.4 France Status and Prospect (2012-2023) 1.4.5 Russia Status and Prospect (2012-2023) 1.4.6 Benelux Status and Prospect (2012-2023) 1.4.7 Italy Status and Prospect (2012-2023) 1.4.8 Spain Status and Prospect (2012-2023) 1.5 Europe Sales and Revenue ofSales and Revenue of Tissue Engineered Skin Substitutes (2012-2023) 1.5.1 Europe Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Europe Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Tissue Engineered Skin Substitutes 2.2 Raw Material Analysis of Tissue Engineered Skin Substitutes 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Tissue Engineered Skin Substitutes 2.4 Other Costs Analysis of Tissue Engineered Skin Substitutes 2.5 Manufacturing Cost Structure Analysis of Tissue Engineered Skin Substitutes 2.6 Manufacturing Process Analysis of Tissue Engineered Skin Substitutes 2.7 Raw Materials Sources of Tissue Engineered Skin Substitutes Major Manufacturers in 2018 2.8 Downstream Buyers 3 Europe Tissue Engineered Skin Substitutes Players/Suppliers Profiles and Sales Data 3.1 Amarantus BioScience Holdings 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Tissue Engineered Skin Substitutes Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Amarantus BioScience Holdings Different Types of Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Volume in Different Applications and Its Application Share 3.2 Acelity L.P., Inc. 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Tissue Engineered Skin Substitutes Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Acelity L.P., Inc. Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Acelity L.P., Inc. Different Types of Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Acelity L.P., Inc. Tissue Engineered Skin Substitutes Volume in Different Applications and Its Application Share 3.3 BSN medical 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Tissue Engineered Skin Substitutes Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 BSN medical Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 BSN medical Different Types of Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 BSN medical Tissue Engineered Skin Substitutes Volume in Different Applications and Its Application Share 3.4 Integra LifeSciences Corporation 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Tissue Engineered Skin Substitutes Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Integra LifeSciences Corporation Different Types of Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Volume in Different Applications and Its Application Share 3.5 Medtronic (Covidien) 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Tissue Engineered Skin Substitutes Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Medtronic (Covidien) Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Medtronic (Covidien) Different Types of Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Medtronic (Covidien) Tissue Engineered Skin Substitutes Volume in Different Applications and Its Application Share 3.6 Molnlycke Health Care 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Tissue Engineered Skin Substitutes Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Molnlycke Health Care Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Molnlycke Health Care Different Types of Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Molnlycke Health Care Tissue Engineered Skin Substitutes Volume in Different Applications and Its Application Share 3.7 Smith & Nephew plc 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Tissue Engineered Skin Substitutes Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Smith & Nephew plc Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Smith & Nephew plc Different Types of Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Smith & Nephew plc Tissue Engineered Skin Substitutes Volume in Different Applications and Its Application Share 3.8 Organogenesis, Inc 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Tissue Engineered Skin Substitutes Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Organogenesis, Inc Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Organogenesis, Inc Different Types of Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Organogenesis, Inc Tissue Engineered Skin Substitutes Volume in Different Applications and Its Application Share 4 Europe Tissue Engineered Skin Substitutes Competition by Players/Manufacturers, Region, Type and Application 4.1 Europe Tissue Engineered Skin Substitutes Market Competition by Players/Manufacturers 4.1.1 Europe Tissue Engineered Skin Substitutes Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Europe Tissue Engineered Skin Substitutes Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Europe Tissue Engineered Skin Substitutes Sales and Revenue by Type 4.2.1 Europe Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Europe Tissue Engineered Skin Substitutes Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Europe Tissue Engineered Skin Substitutes Sales and Revenue by Application 4.3.1 Europe Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Europe Tissue Engineered Skin Substitutes Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Europe Tissue Engineered Skin Substitutes Sales (K Units) by Application 5 Germany Tissue Engineered Skin Substitutes (Sales, Revenue and Price) 5.1 Germany Tissue Engineered Skin Substitutes Sales and Value (2012-2017) 5.1.1 Germany Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Germany Tissue Engineered Skin Substitutes Revenue and Growth Rate (2012-2017) 5.1.3 Germany Tissue Engineered Skin Substitutes Sales Price (USD/Unit) Trend (2012-2017) 5.2 Germany Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Type 5.3 Germany Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Application 6 UK Tissue Engineered Skin Substitutes (Sales, Revenue and Price) 6.1 UK Tissue Engineered Skin Substitutes Sales and Value (2012-2017) 6.1.1 UK Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (2012-2017) 6.1.2 UK Tissue Engineered Skin Substitutes Revenue and Growth Rate (2012-2017) 6.1.3 UK Tissue Engineered Skin Substitutes Sales Price (USD/Unit) Trend (2012-2017) 6.2 UK Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Type 6.3 UK Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Application 7 France Tissue Engineered Skin Substitutes (Sales, Revenue and Price) 7.1 France Tissue Engineered Skin Substitutes Sales and Value (2012-2017) 7.1.1 France Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (2012-2017) 7.1.2 France Tissue Engineered Skin Substitutes Revenue and Growth Rate (2012-2017) 7.1.3 France Tissue Engineered Skin Substitutes Sales Price (USD/Unit) Trend (2012-2017) 7.2 France Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Type 7.3 France Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Application 8 Russia Tissue Engineered Skin Substitutes (Sales, Revenue and Price) 8.1 Russia Tissue Engineered Skin Substitutes Sales and Value (2012-2017) 8.1.1 Russia Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Russia Tissue Engineered Skin Substitutes Revenue and Growth Rate (2012-2017) 8.1.3 Russia Tissue Engineered Skin Substitutes Sales Price (USD/Unit) Trend (2012-2017) 8.2 Russia Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Type 8.3 Russia Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Application 9 Benelux Tissue Engineered Skin Substitutes (Sales, Revenue and Price) 9.1 Benelux Tissue Engineered Skin Substitutes Sales and Value (2012-2017) 9.1.1 Benelux Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (2012-2017) 9.1.2 Benelux Tissue Engineered Skin Substitutes Revenue and Growth Rate (2012-2017) 9.1.3 Benelux Tissue Engineered Skin Substitutes Sales Price (USD/Unit) Trend (2012-2017) 9.2 Benelux Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Type 9.3 Benelux Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Application 10 Italy Tissue Engineered Skin Substitutes (Sales, Revenue and Price) 10.1 Italy Tissue Engineered Skin Substitutes Sales and Value (2012-2017) 10.1.1 Italy Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Italy Tissue Engineered Skin Substitutes Revenue and Growth Rate (2012-2017) 10.1.3 Italy Tissue Engineered Skin Substitutes Sales Price (USD/Unit) Trend (2012-2017) 10.2 Italy Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Type 10.3 Italy Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Application 11 Spain Tissue Engineered Skin Substitutes (Sales, Revenue and Price) 11.1 Spain Tissue Engineered Skin Substitutes Sales and Value (2012-2017) 11.1.1 Spain Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Spain Tissue Engineered Skin Substitutes Revenue and Growth Rate (2012-2017) 11.1.3 Spain Tissue Engineered Skin Substitutes Sales Price (USD/Unit) Trend (2012-2017) 11.2 Spain Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Type 11.3 Spain Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Europe Tissue Engineered Skin Substitutes Market Forecast (2018-2023) 13.1 Europe Tissue Engineered Skin Substitutes Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Europe Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Europe Tissue Engineered Skin Substitutes Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Europe Tissue Engineered Skin Substitutes Price and Trend Forecast (2018-2023) 13.2 Europe Tissue Engineered Skin Substitutes Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Europe Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Europe Tissue Engineered Skin Substitutes Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 Germany Tissue Engineered Skin Substitutes Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 UK Tissue Engineered Skin Substitutes Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 France Tissue Engineered Skin Substitutes Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Russia Tissue Engineered Skin Substitutes Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 France Tissue Engineered Skin Substitutes Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Italy Tissue Engineered Skin Substitutes Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Spain Tissue Engineered Skin Substitutes Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Europe Tissue Engineered Skin Substitutes Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Europe Tissue Engineered Skin Substitutes Sales Forecast by Type (2018-2023) 13.3.2 Europe Tissue Engineered Skin Substitutes Revenue Forecast by Type (2018-2023) 13.3.3 Europe Tissue Engineered Skin Substitutes Price Forecast by Type (2018-2023) 13.4 Europe Tissue Engineered Skin Substitutes Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Europe Market Size (Million USD) Comparison 2012-2023 Table Europe Market Tissue Engineered Skin Substitutes Revenue (Million USD) Comparison by Regions 2012-2023 Table Europe Tissue Engineered Skin Substitutes Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Europe Tissue Engineered Skin Substitutes Sales (K Units) by Application (2016-2023) Figure Product Picture of Tissue Engineered Skin Substitutes Table Europe Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Europe Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Types in 2017 Figure Acellular Picture Figure Cellular Allogeneic Picture Figure Cellular Autologous Picture Table Europe Tissue Engineered Skin Substitutes Sales (K Units) Comparison by Applications (2012-2023) Figure Europe Sales Market Share of Tissue Engineered Skin Substitutes by Applications in 2017 Figure Burn Injury Picture Figure Diabetic Picture Figure Vascular Ulcer Picture Table Europe Market Tissue Engineered Skin Substitutes Revenue (Million USD) Comparison by Regions 2012-2023 Figure Germany Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (2012-2023) Figure UK Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (2012-2023) Figure France Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (2012-2023) Figure Russia Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (2012-2023) Figure Benelux Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (2012-2023) Figure Italy Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (2012-2023) Figure Spain Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (2012-2023) Figure Europe Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Tissue Engineered Skin Substitutes Table Industry News List of Tissue Engineered Skin Substitutes Figure Industry Chain Structure of Tissue Engineered Skin Substitutes Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Tissue Engineered Skin Substitutes in 2017 Figure Manufacturing Process Analysis of Tissue Engineered Skin Substitutes Table Raw Materials Sources of Tissue Engineered Skin Substitutes Major Manufacturers Europe Table Major Buyers of Tissue Engineered Skin Substitutes Table Amarantus BioScience Holdings Basic Information List Table Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Sales Growth Rate (2012-2017) Figure Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Sales Europe Market Share (%) (2012-2017) Figure Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Revenue Europe Market Share (%) (2012-2017) Table Acellular Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Allogeneic Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Autologous Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Volume in Burn Injury and Its Application Share Table Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Volume in Diabetic and Its Application Share Table Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Volume in Vascular Ulcer and Its Application Share Table Acelity L.P., Inc. Basic Information List Table Acelity L.P., Inc. Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Acelity L.P., Inc. Tissue Engineered Skin Substitutes Sales Growth Rate (2012-2017) Figure Acelity L.P., Inc. Tissue Engineered Skin Substitutes Sales Europe Market Share (%) (2012-2017) Figure Acelity L.P., Inc. Tissue Engineered Skin Substitutes Revenue Europe Market Share (%) (2012-2017) Table Acellular Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Allogeneic Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Autologous Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Acelity L.P., Inc. Tissue Engineered Skin Substitutes Volume in Burn Injury and Its Application Share Table Acelity L.P., Inc. Tissue Engineered Skin Substitutes Volume in Diabetic and Its Application Share Table Acelity L.P., Inc. Tissue Engineered Skin Substitutes Volume in Vascular Ulcer and Its Application Share Table BSN medical Basic Information List Table BSN medical Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure BSN medical Tissue Engineered Skin Substitutes Sales Growth Rate (2012-2017) Figure BSN medical Tissue Engineered Skin Substitutes Sales Europe Market Share (%) (2012-2017) Figure BSN medical Tissue Engineered Skin Substitutes Revenue Europe Market Share (%) (2012-2017) Table Acellular Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Allogeneic Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Autologous Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table BSN medical Tissue Engineered Skin Substitutes Volume in Burn Injury and Its Application Share Table BSN medical Tissue Engineered Skin Substitutes Volume in Diabetic and Its Application Share Table BSN medical Tissue Engineered Skin Substitutes Volume in Vascular Ulcer and Its Application Share Table Integra LifeSciences Corporation Basic Information List Table Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Sales Growth Rate (2012-2017) Figure Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Sales Europe Market Share (%) (2012-2017) Figure Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Revenue Europe Market Share (%) (2012-2017) Table Acellular Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Allogeneic Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Autologous Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Volume in Burn Injury and Its Application Share Table Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Volume in Diabetic and Its Application Share Table Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Volume in Vascular Ulcer and Its Application Share Table Medtronic (Covidien) Basic Information List Table Medtronic (Covidien) Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Medtronic (Covidien) Tissue Engineered Skin Substitutes Sales Growth Rate (2012-2017) Figure Medtronic (Covidien) Tissue Engineered Skin Substitutes Sales Europe Market Share (%) (2012-2017) Figure Medtronic (Covidien) Tissue Engineered Skin Substitutes Revenue Europe Market Share (%) (2012-2017) Table Acellular Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Allogeneic Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Autologous Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Medtronic (Covidien) Tissue Engineered Skin Substitutes Volume in Burn Injury and Its Application Share Table Medtronic (Covidien) Tissue Engineered Skin Substitutes Volume in Diabetic and Its Application Share Table Medtronic (Covidien) Tissue Engineered Skin Substitutes Volume in Vascular Ulcer and Its Application Share Table Molnlycke Health Care Basic Information List Table Molnlycke Health Care Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Molnlycke Health Care Tissue Engineered Skin Substitutes Sales Growth Rate (2012-2017) Figure Molnlycke Health Care Tissue Engineered Skin Substitutes Sales Europe Market Share (%) (2012-2017) Figure Molnlycke Health Care Tissue Engineered Skin Substitutes Revenue Europe Market Share (%) (2012-2017) Table Acellular Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Allogeneic Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Autologous Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Molnlycke Health Care Tissue Engineered Skin Substitutes Volume in Burn Injury and Its Application Share Table Molnlycke Health Care Tissue Engineered Skin Substitutes Volume in Diabetic and Its Application Share Table Molnlycke Health Care Tissue Engineered Skin Substitutes Volume in Vascular Ulcer and Its Application Share Table Smith & Nephew plc Basic Information List Table Smith & Nephew plc Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Smith & Nephew plc Tissue Engineered Skin Substitutes Sales Growth Rate (2012-2017) Figure Smith & Nephew plc Tissue Engineered Skin Substitutes Sales Europe Market Share (%) (2012-2017) Figure Smith & Nephew plc Tissue Engineered Skin Substitutes Revenue Europe Market Share (%) (2012-2017) Table Acellular Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Allogeneic Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Autologous Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Smith & Nephew plc Tissue Engineered Skin Substitutes Volume in Burn Injury and Its Application Share Table Smith & Nephew plc Tissue Engineered Skin Substitutes Volume in Diabetic and Its Application Share Table Smith & Nephew plc Tissue Engineered Skin Substitutes Volume in Vascular Ulcer and Its Application Share Table Organogenesis, Inc Basic Information List Table Organogenesis, Inc Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Organogenesis, Inc Tissue Engineered Skin Substitutes Sales Growth Rate (2012-2017) Figure Organogenesis, Inc Tissue Engineered Skin Substitutes Sales Europe Market Share (%) (2012-2017) Figure Organogenesis, Inc Tissue Engineered Skin Substitutes Revenue Europe Market Share (%) (2012-2017) Table Acellular Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Allogeneic Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Autologous Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Organogenesis, Inc Tissue Engineered Skin Substitutes Volume in Burn Injury and Its Application Share Table Organogenesis, Inc Tissue Engineered Skin Substitutes Volume in Diabetic and Its Application Share Table Organogenesis, Inc Tissue Engineered Skin Substitutes Volume in Vascular Ulcer and Its Application Share Table Basic Information List Table Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Tissue Engineered Skin Substitutes Sales Growth Rate (2012-2017) Figure Tissue Engineered Skin Substitutes Sales Europe Market Share (%) (2012-2017) Figure Tissue Engineered Skin Substitutes Revenue Europe Market Share (%) (2012-2017) Table Acellular Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Allogeneic Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Autologous Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Tissue Engineered Skin Substitutes Volume in Burn Injury and Its Application Share Table Tissue Engineered Skin Substitutes Volume in Diabetic and Its Application Share Table Tissue Engineered Skin Substitutes Volume in Vascular Ulcer and Its Application Share Table Company Basic Information List Table Company Tissue Engineered Skin Substitutes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Tissue Engineered Skin Substitutes Sales Growth Rate (2012-2017) Figure Company Tissue Engineered Skin Substitutes Sales Europe Market Share (%) (2012-2017) Figure Company Tissue Engineered Skin Substitutes Revenue Europe Market Share (%) (2012-2017) Table Acellular Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Allogeneic Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cellular Autologous Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Tissue Engineered Skin Substitutes Volume in Burn Injury and Its Application Share Table Company Tissue Engineered Skin Substitutes Volume in Diabetic and Its Application Share Table Company Tissue Engineered Skin Substitutes Volume in Vascular Ulcer and Its Application Share Table Europe Tissue Engineered Skin Substitutes Sales (K Units) by Players/Manufacturers (2012-2017) Table Europe Tissue Engineered Skin Substitutes Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Europe Tissue Engineered Skin Substitutes Sales Market Share (%) by Players/Manufacturers Figure 2017 Europe Tissue Engineered Skin Substitutes Sales Share by Players/Manufacturers Table Europe Tissue Engineered Skin Substitutes Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Europe Tissue Engineered Skin Substitutes Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Europe Tissue Engineered Skin Substitutes Revenue Market Share (%) Players Figure 2017 Europe Tissue Engineered Skin Substitutes Revenue Market Share (%) Players Table Europe Tissue Engineered Skin Substitutes Sales (K Units) and Market Share (%) by Type (2012-2017) Table Europe Tissue Engineered Skin Substitutes Sales Share by Type (2012-2017) Figure Sales Market Share of Tissue Engineered Skin Substitutes by Type (2012-2017) Figure Europe Tissue Engineered Skin Substitutes Sales Growth Rate (%) by Type (2012-2017) Table Europe Tissue Engineered Skin Substitutes Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Europe Tissue Engineered Skin Substitutes Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Tissue Engineered Skin Substitutes by Type (2012-2017) Figure Europe Tissue Engineered Skin Substitutes Revenue Growth Rate by Type (2012-2017) Table Europe Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Regions (2012-2017) Table Europe Tissue Engineered Skin Substitutes Sales Share by Regions (2012-2017) Figure Sales Market Share of Tissue Engineered Skin Substitutes by Regions (2012-2017) Figure Europe Tissue Engineered Skin Substitutes Sales Market Share by Regions in 2017 Table Europe Tissue Engineered Skin Substitutes Revenue (Million USD) and Market Share by Regions (2012-2017) Table Europe Tissue Engineered Skin Substitutes Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Tissue Engineered Skin Substitutes by Regions (2012-2017) Figure Europe Tissue Engineered Skin Substitutes Revenue Market Share by Regions in 2017 Table Europe Tissue Engineered Skin Substitutes Sales (K Units) and Market Share by Application (2012-2017) Table Europe Tissue Engineered Skin Substitutes Sales Share (%) by Application (2012-2017) Figure Europe Tissue Engineered Skin Substitutes Sales Market Share by Application (2012-2017) Figure Europe Tissue Engineered Skin Substitutes Sales Market Share by Application (2012-2017) Figure Germany Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (%) (2012-2017) Figure Germany Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Germany Tissue Engineered Skin Substitutes Sales Price (USD/Unit) Trend (2012-2017) Table Germany Tissue Engineered Skin Substitutes Sales (K Units) by Type (2012-2017) Table Germany Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Type (2012-2017) Figure Germany Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Type in 2017 Table Germany Tissue Engineered Skin Substitutes Sales (K Units) by Applications (2012-2017) Table Germany Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Applications (2012-2017) Figure Germany Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Applications in 2017 Figure UK Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (2012-2017) Figure UK Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure UK Tissue Engineered Skin Substitutes Sales Price (USD/Unit) Trend (2012-2017) Table UK Tissue Engineered Skin Substitutes Sales (K Units) by Type (2012-2017) Table UK Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Type (2012-2017) Figure UK Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Type in 2017 Table UK Tissue Engineered Skin Substitutes Sales (K Units) by Applications (2012-2017) Table UK Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Applications (2012-2017) Figure UK Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Applications in 2017 Figure France Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (2012-2017) Figure France Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure France Tissue Engineered Skin Substitutes Sales Price (USD/Unit) Trend (2012-2017) Table France Tissue Engineered Skin Substitutes Sales (K Units) by Type (2012-2017) Table France Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Type (2012-2017) Figure France Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Type in 2017 Table France Tissue Engineered Skin Substitutes Sales (K Units) by Applications (2012-2017) Table France Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Applications (2012-2017) Figure France Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Applications in 2017 Figure Russia Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (2012-2017) Figure Russia Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Russia Tissue Engineered Skin Substitutes Sales Price (USD/Unit) Trend (2012-2017) Table Russia Tissue Engineered Skin Substitutes Sales (K Units) by Type (2012-2017) Table Russia Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Type (2012-2017) Figure Russia Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Type in 2017 Table Russia Tissue Engineered Skin Substitutes Sales (K Units) by Applications (2012-2017) Table Russia Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Applications (2012-2017) Figure Russia Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Applications in 2017 Figure Italy Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (2012-2017) Figure Italy Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Italy Tissue Engineered Skin Substitutes Sales Price (USD/Unit) Trend (2012-2017) Table Italy Tissue Engineered Skin Substitutes Sales (K Units) by Type (2012-2017) Table Italy Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Type (2012-2017) Figure Italy Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Type in 2017 Table Italy Tissue Engineered Skin Substitutes Sales (K Units) by Applications (2012-2017) Table Italy Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Applications (2012-2017) Figure Italy Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Applications in 2017 Figure Benelux Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (2012-2017) Figure Benelux Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Benelux Tissue Engineered Skin Substitutes Sales Price (USD/Unit) Trend (2012-2017) Table Benelux Tissue Engineered Skin Substitutes Sales (K Units) by Type (2012-2017) Table Benelux Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Type (2012-2017) Figure Benelux Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Type in 2017 Table Benelux Tissue Engineered Skin Substitutes Sales (K Units) by Applications (2012-2017) Table Benelux Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Applications (2012-2017) Figure Benelux Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Applications in 2017 Figure Spain Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (2012-2017) Figure Spain Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Spain Tissue Engineered Skin Substitutes Sales Price (USD/Unit) Trend (2012-2017) Table Spain Tissue Engineered Skin Substitutes Sales (K Units) by Type (2012-2017) Table Spain Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Type (2012-2017) Figure Spain Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Type in 2017 Table Spain Tissue Engineered Skin Substitutes Sales (K Units) by Applications (2012-2017) Table Spain Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Applications (2012-2017) Figure Spain Tissue Engineered Skin Substitutes Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Europe Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Tissue Engineered Skin Substitutes Price and Trend Forecast (2018-2023) Table Europe Tissue Engineered Skin Substitutes Sales (K Units) Forecast by Regions (2018-2023) Figure Europe Tissue Engineered Skin Substitutes Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Europe Tissue Engineered Skin Substitutes Sales (K Units) Market Share Forecast by Regions in 2023 Table Europe Tissue Engineered Skin Substitutes Revenue (Million USD) Forecast by Regions (2018-2023) Figure Europe Tissue Engineered Skin Substitutes Revenue Market Share Forecast by Regions (2018-2023) Figure Europe Tissue Engineered Skin Substitutes Revenue Market Share Forecast by Regions in 2023 Figure Germany Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Germany Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure France Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure France Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure UK Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure UK Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Russia Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Russia Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Italy Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Italy Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Spain Tissue Engineered Skin Substitutes Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Spain Tissue Engineered Skin Substitutes Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Europe Tissue Engineered Skin Substitutes Sales (K Units) Forecast by Type (2018-2023) Figure Europe Tissue Engineered Skin Substitutes Sales Market Share Forecast by Type (2018-2023) Table Europe Tissue Engineered Skin Substitutes Revenue (Million USD) Forecast by Type (2018-2023) Figure Europe Tissue Engineered Skin Substitutes Revenue Market Share Forecast by Type (2018-2023) Table Europe Tissue Engineered Skin Substitutes Price (USD/Unit) Forecast by Type (2018-2023) Table Europe Tissue Engineered Skin Substitutes Sales (K Units) Forecast by Application (2018-2023) Figure Europe Tissue Engineered Skin Substitutes Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Amarantus BioScience Holdings Acelity L.P., Inc. BSN medical Integra LifeSciences Corporation Medtronic (Covidien) Molnlycke Health Care Smith & Nephew plc Organogenesis, Inc